Status:
COMPLETED
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
Lead Sponsor:
University of Kansas Medical Center
Collaborating Sponsors:
VA Office of Research and Development
University of Nebraska
Conditions:
Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether or not CTCs can be detected in blood samples taken from patients diagnosed with small cell lung cancer. The purpose is to compare CTC analysis to tumo...
Detailed Description
Small cell lung cancer (SCLC) is characterized by early dissemination through the blood system with the majority of patients succumbing to their disease in 9-11 months. Despite evaluation of multiple ...
Eligibility Criteria
Inclusion
- Histological proof of small cell lung cancer with extensive stage disease and have been untreated.
- Must be willing to give and sign informed consent.
- Must be 18 years of age
Exclusion
- Less than 18 years of age.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT01173458
Start Date
July 1 2010
End Date
March 1 2015
Last Update
January 10 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Centner
Kansas City, Kansas, United States, 66160
2
University of Nebraska & Omaha VA
Omaha, Nebraska, United States, 68105